Literature DB >> 17854911

Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia.

Seija Lehnardt1, Sabrina Lehmann, David Kaul, Katharina Tschimmel, Olaf Hoffmann, Sabine Cho, Christina Krueger, Robert Nitsch, Andreas Meisel, Joerg R Weber.   

Abstract

Toll-like receptors (TLR) recognize molecular structures associated with pathogens as well as host-derived components and initiate an inflammatory innate immune response. Microglia represent the resident immune host defense and are the major inflammatory cell type in the central nervous system (CNS). We show here that TLR2-deficient mice develop a decreased CNS injury compared to wild type mice in a model of focal cerebral ischemia. TLR2 mRNA is up-regulated in wild type mice during cerebral ischemia. In ischemic brains, TLR2 protein is expressed in lesion-associated microglia. Absence of TLR2 does not affect the recruitment of granulocytes to the infarct region. We conclude that TLR2 in microglia propagates stroke-induced CNS injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17854911     DOI: 10.1016/j.jneuroim.2007.07.023

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  116 in total

Review 1.  The immunology of acute stroke.

Authors:  Ángel Chamorro; Andreas Meisel; Anna M Planas; Xabier Urra; Diederik van de Beek; Roland Veltkamp
Journal:  Nat Rev Neurol       Date:  2012-06-05       Impact factor: 42.937

2.  Painful pathways induced by TLR stimulation of dorsal root ganglion neurons.

Authors:  Jia Qi; Krisztina Buzas; Huiting Fan; Jeffrey I Cohen; Kening Wang; Erik Mont; Dennis Klinman; Joost J Oppenheim; O M Zack Howard
Journal:  J Immunol       Date:  2011-04-22       Impact factor: 5.422

3.  Toll-like receptor 7 preconditioning induces robust neuroprotection against stroke by a novel type I interferon-mediated mechanism.

Authors:  Philberta Y Leung; Susan L Stevens; Amy E B Packard; Nikola S Lessov; Tao Yang; Valerie K Conrad; Noortje N A M van den Dungen; Roger P Simon; Mary P Stenzel-Poore
Journal:  Stroke       Date:  2012-03-08       Impact factor: 7.914

4.  Combination therapy with VELCADE and tissue plasminogen activator is neuroprotective in aged rats after stroke and targets microRNA-146a and the toll-like receptor signaling pathway.

Authors:  Li Zhang; Michael Chopp; Xianshuang Liu; Hua Teng; Tao Tang; Haifa Kassis; Zheng Gang Zhang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-06-21       Impact factor: 8.311

Review 5.  Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS?

Authors:  Catherine E Downes; Peter J Crack
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 6.  Toll-like receptors: new players in myocardial ischemia/reperfusion injury.

Authors:  Tuanzhu Ha; Li Liu; Jim Kelley; Race Kao; David Williams; Chuanfu Li
Journal:  Antioxid Redox Signal       Date:  2011-04-08       Impact factor: 8.401

7.  DIDS protects against neuronal injury by blocking Toll-like receptor 2 activated-mechanisms.

Authors:  Hang Yao; Hady Felfly; Juan Wang; Dan Zhou; Gabriel G Haddad
Journal:  J Neurochem       Date:  2008-12-10       Impact factor: 5.372

Review 8.  Linking oxidative stress to inflammation: Toll-like receptors.

Authors:  Roop Gill; Allan Tsung; Timothy Billiar
Journal:  Free Radic Biol Med       Date:  2010-01-18       Impact factor: 7.376

Review 9.  Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation.

Authors:  Olaf Hoffmann; Frauke Zipp; Joerg R Weber
Journal:  J Mol Med (Berl)       Date:  2009-05-17       Impact factor: 4.599

10.  Ginkgolides and bilobalide protect BV2 microglia cells against OGD/reoxygenation injury by inhibiting TLR2/4 signaling pathways.

Authors:  Jian-Ming Zhou; Sha-Sha Gu; Wang Hong Mei; Jun Zhou; Zhen Zhong Wang; Wei Xiao
Journal:  Cell Stress Chaperones       Date:  2016-08-25       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.